arrow
J

Julia Bielicki

University Children's Hospital Basel
H指数:43
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial

非洲住院的重症社区获得性肺炎儿童中抗生素治疗的逐步减量、最佳用药及总疗程(PediCAP):一项析因随机对照试验

2026-07-230
OAAI
Improving Registration and Dataflows Between Pediatric Oncology Clinics and the Childhood Cancer Registry of Switzerland: Protocol for SwissPedCancer Quality Assurance Study

改进瑞士儿科肿瘤诊所与瑞士儿童癌症登记处的注册和数据流:瑞士PedCancer质量保证研究方案

2026-01-010
PRE
Target product profiles for paediatric formulations of azithromycin and nitrofurantoin

阿奇霉素和呋喃妥因儿科制剂的目标产品概况

2025-12-010
PRE
Rebound of Respiratory Virus Activity and Seasonality to Pre-Pandemic Patterns

呼吸道病毒活动及季节性向疫情前模式的反弹

2025-10-230
OAAI
All-cause mortality and infection-related outcomes of hospital-initiated kangaroo care versus conventional neonatal care for low-birthweight infants: a systematic review and meta-analysis

所有-cause mortality和感染相关结局:医院发起的袋鼠式护理与常规新生儿护理对低出生体重婴儿的对比——一项系统评价和荟萃分析

2025-05-260
OA
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries

在低收入和中等收入国家对引起新生儿败血症的革兰氏阴性菌的三种抗生素联合方案的评估

2024-05-100
OAAI
High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland

高分辨率基因组学鉴定英国和爱尔兰社区获得性肺炎患儿中肺炎链球菌的多样性及疫苗型的持续存在

2024-04-272
OAAI
Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial
2024-03-012
OAAI
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis

世卫组织非洲区域2019年的细菌耐药性负担: 跨国系统分析

2024-02-0145
OAAI
Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial
2024-01-010
OAAI